Faropenem Sodium 200 mg + Potassium Clavulanate Eq. to Clavulanic Acid 125 mg Film-Coated Tablet

Faropenem Sodium 200 mg + Potassium Clavulanate Eq. to Clavulanic Acid 125 mg Film-Coated Tablet is a film-coated tablet formulated with Faropenem Sodium 200 mg + Potassium Clavulanate equivalent to Clavulanic Acid 125 mg. The active ingredient profile is Faropenem Sodium; Potassium Clavulanate, placing the product in the penem antibiotic + beta-lactamase inhibitor combination category. The antibacterial component is paired with a beta-lactamase inhibitor to broaden activity against selected susceptible organisms where the exact combination is approved. The film coating provides a finished oral solid-dosage presentation and may support handling, stability and product acceptability. For website cataloguing, composition, strength, dosage form and release/coating characteristics should be displayed prominently and consistently. The description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and the prescriber’s judgement. Prescription status, precautions, interactions, adverse effects and dosing must be checked against the current approved product label before publication. Manufacturer, licence, storage, shelf-life, pack configuration and market-specific regulatory details should be added only from verified product documentation.